A Multicentre Phase II Randomised Trial of Durvalumab (MEDI4736) Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas
Trial Number
NCT03405454 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
ANZGOG
BGOG